ChatGPT found by study to spread inaccuracies when answering medication questions

Jack Krawczyk discusses how Google Bard helps users connect and communicate -- and what the future holds for the platform. ChatGPT has been found to have shared inaccurate information regarding drug usage, according to new research. In a study led by Long Island University (LIU) in Brooklyn, New York, nearly 75% of drug-related, pharmacist-reviewed responses from the generative AI chatbot were found to be incomplete or wrong. In some cases, ChatGPT, which was developed by OpenAI in San Francisco and released in late 2022, provided "inaccurate responses that could endanger patients," the American Society of Health System Pharmacists (ASHP), headquartered in Bethesda, Maryland, stated in a press release. ChatGPT also generated "fake citations" when asked to cite references to support some responses, the same study also found.